ADHD: GPs are told to review some patients amid drug shortagesBMJ 2023; 382 doi: https://doi.org/10.1136/bmj.p2250 (Published 28 September 2023) Cite this as: BMJ 2023;382:p2250
- Elisabeth Mahase
- The BMJ
GPs have been advised not to start new patients on several drugs for treating attention deficit/hyperactivity disorder that are in short supply in the UK, said the Department of Health and Social Care, because of a combination of manufacturing problems and increasing global demand.
Drugs affected by the disruption, which is expected to last until the end …